Hallandale Pharmacy Reviews 2026: Is It Legit?
Published August 28, 2026
Last verified: August 28, 2026
Quick answer
Hallandale Pharmacy is a real 503A compounding pharmacy in Fort Lauderdale, Florida, and Ozari Health publicly identifies Hallandale as one of its pharmacy partners. Hallandale says it is PCAB accredited and its website currently states that it is LegitScript Certified. Its current product catalog includes compounded semaglutide and tirzepatide.
Hallandale also has a public FDA regulatory history. FDA lists a March 2020 warning letter, a September 2021 amended Form 483, a May 2022 warning-letter closeout, and a June 2025 Form FDA 483. A Form 483 records inspection observations and is not itself a final FDA determination of a violation.
Patient reviews are mixed. BBB currently shows both positive and negative experiences, including praise for problem resolution and complaints involving perceived effectiveness, shipping, service, and product issues. Patient anecdotes can identify themes, but they cannot establish the potency or quality of a particular vial.
What is Hallandale Pharmacy?
Hallandale Pharmacy is the trade name used by Pharmcore Inc. for a compounding pharmacy located at:
2666 SW 36th Street
Fort Lauderdale, FL 33312
Hallandale describes itself as a 503A designated pharmacy. Its website says it works with more than 15,000 prescribing practitioners and operates a 60,000-square-foot facility.
The pharmacy's public catalog spans multiple categories, including weight management, hormone replacement, men's and women's health, dermatology, sexual wellness, fertility, peptide therapy, IV therapy, and other compounded medications.
Hallandale Pharmacy quick facts
| Question | Current public information |
|---|---|
| Is Hallandale a 503A pharmacy? | Yes |
| Location | Fort Lauderdale, Florida |
| Does Ozari use Hallandale? | Yes, as a named pharmacy partner |
| PCAB accreditation | Hallandale and Ozari currently say yes |
| LegitScript | Hallandale's site currently says certified |
| Compounded semaglutide listed? | Yes |
| Compounded tirzepatide listed? | Yes |
| Are compounded GLP-1 drugs FDA approved? | No |
| Public FDA inspection history? | Yes |
Is Hallandale Pharmacy legit?
"Legit" can mean several things.
Is Hallandale an actual pharmacy?
Yes. Hallandale operates a physical facility, publishes its address and contact information, and appears in FDA's public human-drug-compounding records as Pharmcore Inc. dba Hallandale Pharmacy.
Is Hallandale a 503A pharmacy?
Yes. FDA's compounding database identifies it as a 503A facility.
Under section 503A of the Federal Food, Drug, and Cosmetic Act, qualifying compounded drugs are generally prepared for an identified individual patient based on a valid prescription and other statutory conditions.
Is Hallandale "FDA approved"?
That is not the correct terminology.
FDA approves finished drugs, not 503A pharmacies in the same sense. FDA specifically states that compounded drugs are not FDA approved and do not undergo the same premarket review for safety, effectiveness, and quality as approved finished drug products.
What does Hallandale's FDA history show?
FDA's current public compounding database lists:
| Date | FDA record |
|---|---|
| March 11, 2020 | Warning Letter |
| September 24, 2021 | Amended Form 483 |
| May 3, 2022 | Warning Letter Close Out |
| May 3, 2022 | State Referral / FMD-145 records |
| June 13, 2025 | Form FDA 483 |
| November 20, 2025 | FMD-145 Letter |
The June 2025 inspection resulted in two observations concerning sterile-compounding practices. One involved certain wipes being used within ISO-5 hoods after storage/opening in an ISO-7 area. The other concerned whether smoke studies fully simulated routine dynamic processing conditions.
The document itself states that the observations do not represent a final FDA determination regarding compliance.
For a deeper timeline, see Hallandale Pharmacy FDA History.
What do Hallandale Pharmacy reviews say?
As of our August 28, 2026 review, BBB displayed a 3.13/5 average from 52 customer reviews and an A+ BBB rating. Its complaint page showed 108 complaints in the prior three years.
Common positive themes include:
- professional resolution of a vial or order issue;
- satisfactory packaging or fulfillment;
- positive treatment experiences;
- responsive service in some cases.
Common negative themes include:
- perceived lack of medication effect;
- vial fill or dosing concerns;
- delivery delays or order problems;
- frustration with communication.
Those reviews deserve context.
A patient saying medication "felt weaker" is not a laboratory potency assay. Appetite, weight change, dose, concentration, storage, injection technique, prior GLP-1 exposure, and individual clinical response can all affect perception.
At the same time, recurring complaints should not be dismissed. They are one data point to compare with licensing, accreditation, FDA records, pharmacy testing disclosures, and the patient's own clinician.
What does Hallandale say about quality?
Hallandale's quality page says:
- its 503A operation follows USP 797 sterile-compounding standards;
- each sterile batch undergoes analytical testing;
- it performs stability studies supporting beyond-use dating and storage conditions;
- APIs are sourced from FDA-registered API manufacturers;
- suppliers undergo vendor review;
- Certificates of Analysis are internally verified;
- its facility uses controlled cleanrooms and environmental monitoring.
These are Hallandale's own quality disclosures, not independent guarantees. They should be read alongside third-party accreditation and regulatory records.
How Ozari Health works with Hallandale Pharmacy
Ozari Health publicly identifies Hallandale Pharmacy as one of its two U.S.-licensed 503A compounding pharmacy partners, alongside VialsRx. Ozari says every prescription is patient-specific, written by a licensed prescriber, and routed according to the patient's state, medication and dose, and current pharmacy capacity.
Patients do not select the dispensing pharmacy by request. The prescription label identifies which pharmacy prepared the medication.
That disclosure creates an important distinction for patients researching GLP-1 telehealth companies: Ozari does not describe fulfillment only as coming from an unnamed "partner pharmacy." Patients can independently research Hallandale's facility, credentials, public FDA history, product catalog, and contact information.
Should you choose a telehealth provider based only on Hallandale?
Usually not.
The pharmacy matters, but so do:
- clinician quality and availability;
- total ongoing cost;
- whether prices rise with dose;
- refill and titration support;
- order-problem escalation;
- cancellation terms;
- pharmacy transparency;
- state coverage;
- whether an FDA-approved option can meet the patient's needs.
Two telehealth companies can use the same Hallandale Pharmacy while providing very different patient experiences.
Frequently asked questions
Is Hallandale Pharmacy a real compounding pharmacy?
Yes. FDA identifies Pharmcore Inc. dba Hallandale Pharmacy as a 503A facility.
Does Ozari Health use Hallandale Pharmacy?
Yes. Ozari publicly identifies Hallandale as one of its two 503A pharmacy partners.
Is Hallandale Pharmacy PCAB accredited?
Hallandale and Ozari currently state that it holds PCAB accreditation.
Is Hallandale LegitScript certified?
Hallandale's current website states that it is LegitScript Certified.
Is Hallandale semaglutide FDA approved?
No. Compounded semaglutide is not an FDA-approved finished drug product.
Did FDA issue Hallandale a warning letter?
Yes. FDA issued a warning letter in 2020, and FDA's database lists a warning-letter closeout dated May 3, 2022.
Did Hallandale receive a Form 483 in 2025?
Yes. FDA issued a Form 483 on June 13, 2025. A Form 483 contains inspection observations and is not a final FDA determination.
Medical and regulatory disclaimer
This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved finished drug products and are not reviewed by FDA for safety, effectiveness, or quality before marketing in the same way as FDA-approved drugs. A licensed clinician must determine whether a compounded medication is appropriate for an individual patient and whether the prescription meets applicable federal and state requirements.
Pharmacy availability, formulations, prices, state coverage, provider relationships, credentials, and regulatory records can change. Verify current information before making a treatment decision.
Sources
Explore Ozari's pharmacy standards
Ozari Health publicly names the pharmacies that prepare eligible patient-specific compounded GLP-1 prescriptions.
Related Articles
Managing Weight Regain After Gastric Sleeve With GLP-1 Telehealth
Explore GLP-1 treatment via telehealth for effective weight regain management after gastric sleeve surgery. Discover proven benefits today!
Read more →generalHallandale Pharmacy FDA History: 483s, Warning Letter & What They Mean
A neutral timeline of Hallandale Pharmacy FDA records, including the 2020 warning letter, 2022 closeout, 2025 Form 483, and how to interpret each record.
Read more →generalHallandale Pharmacy Semaglutide Reviews: 2026 Guide
What to know about Hallandale compounded semaglutide, including current concentrations, patient reviews, FDA status, quality signals, storage, and Ozari fulfillment.
Read more →